Stanford University (SU) is applying to the National Cancer Institute (NCI) for three years of funding of a Cancer Center Support Grant (CCSG) and for designation as a Comprehensive Cancer Center on the basis of three years of preparation with generous intramural support. The membership of the Center consists of 260 faculty members representing four Schools at SU (Medicine, Engineering, Humanities and Sciences, and the Graduate School of Business), and the Northern California Cancer Center (NCCC) with whom SU has a formal affiliation agreement. The CCSG proposal builds on institutional strengths in technology development and in translational research. Ten Programs cover the areas of Basic, Clinical/Translational and Population Sciences Research in cancer (Cancer Biology, Radiation Biology, Cancer Stem Cells, Imaging Research, Molecular Profiling of Cancer, Lymphoma and Hodgkin's Disease, Cancer Immunology and Immunotherapy, Hematopoietic Cell Transplantation and Immune Reconstitution, Cancer Epidemiology and Cancer Prevention). Areas under development include research in Solid Tumor Oncology and Experimental Therapeutics. Ten Shared Resources established with funding from SU, the School of Medicine and the two Hospitals at SU Medical Center, support the investigations in experimental and clinical research. The SU Cancer Center has a research base of $37,682,289 in direct costs from the NCI, $48,334,019 from the National Institutes of Health (other than NCI), and $15,140,739 awarded for cancer research by other peer-reviewed sources. This CCSG Application is enthusiastically supported by the University President who has committed funds to match those from the NCI, the four Deans, and the faculty involved in Cancer Research at SU and NCCC.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA124435-03
Application #
7623570
Study Section
Subcommittee G - Education (NCI)
Program Officer
Marino, Michael A
Project Start
2007-06-04
Project End
2010-05-31
Budget Start
2009-06-01
Budget End
2010-05-31
Support Year
3
Fiscal Year
2009
Total Cost
$1,611,344
Indirect Cost
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Im, Hogune; Rao, Varsha; Sridhar, Kunju et al. (2018) Distinct transcriptomic and exomic abnormalities within myelodysplastic syndrome marrow cells. Leuk Lymphoma 59:2952-2962
Huang, Min; Zhu, Li; Garcia, Jacqueline S et al. (2018) Brd4 regulates the expression of essential autophagy genes and Keap1 in AML cells. Oncotarget 9:11665-11676
Chiou, Shin-Heng; Dorsch, Madeleine; Kusch, Eva et al. (2018) Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance. Sci Rep 8:14008
Breslow, David K; Hoogendoorn, Sascha; Kopp, Adam R et al. (2018) A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies. Nat Genet 50:460-471
Chu, Lisa W; Till, Cathee; Yang, Baiyu et al. (2018) Circadian genes and risk of prostate cancer in the prostate cancer prevention trial. Mol Carcinog 57:462-466
Patel, Manali I; Sundaram, Vandana; Desai, Manisha et al. (2018) Effect of a Lay Health Worker Intervention on Goals-of-Care Documentation and on Health Care Use, Costs, and Satisfaction Among Patients With Cancer: A Randomized Clinical Trial. JAMA Oncol 4:1359-1366
Trieu, Vanessa; Pinto, Harlan; Riess, Jonathan W et al. (2018) Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck. Oncologist 23:764-e86
Kuonen, François; Surbeck, Isabelle; Sarin, Kavita Y et al. (2018) TGF?, Fibronectin and Integrin ?5?1 Promote Invasion in Basal Cell Carcinoma. J Invest Dermatol 138:2432-2442
Gee, Marvin H; Han, Arnold; Lofgren, Shane M et al. (2018) Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell 172:549-563.e16
Malta, Tathiane M; Sokolov, Artem; Gentles, Andrew J et al. (2018) Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell 173:338-354.e15

Showing the most recent 10 out of 322 publications